Eversept Partners, LP
Top Portfolio Positions
88 positions ·
$1,565,606,873 total
· as of Dec 31, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| QQQ |
Invesco Qqq Trust, Series 1
|
225,000 | $138,219,750 | 8.83% |
| GSK |
GSK plc
|
2,679,721 | $131,413,517 | 8.39% |
| UTHR |
UNITED THERAPEUTICS Corp
|
252,592 | $123,075,452 | 7.86% |
| NTRA |
Natera, Inc.
|
334,493 | $76,629,001 | 4.89% |
| SNDX |
Syndax Pharmaceuticals Inc
|
3,314,408 | $69,635,712 | 4.45% |
| VRDN |
Viridian Therapeutics, Inc.\DE
|
1,782,235 | $55,463,153 | 3.54% |
| PCVX |
Vaxcyte, Inc.
|
1,197,722 | $55,262,893 | 3.53% |
| TVTX |
Travere Therapeutics, Inc.
|
1,174,968 | $44,895,527 | 2.87% |
| HCA |
HCA Healthcare, Inc.
|
95,874 | $44,759,735 | 2.86% |
| DHR |
Danaher Corp /De/
|
186,262 | $42,639,097 | 2.72% |
Portfolio Trend
Holdings in ENGN
Export CSV
1 of 1 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $4,116,190 | 455,835 | Shares | Sole | 2026-02-17 | |
| No quarters match your search. | ||||||